✦ LIBER ✦
PND44 Cost-Utility Analysis and Cost-Minimisation Analysis of Sabril® (Vigabatrin) in Drug-Resistant Epilepsy From Payer's Perspective in Poland
✍ Scribed by Kawalec, P.; Holko, P.; Lis, J.; Glasek, M.
- Book ID
- 122302365
- Publisher
- John Wiley and Sons
- Year
- 2012
- Tongue
- English
- Weight
- 61 KB
- Volume
- 15
- Category
- Article
- ISSN
- 1098-3015
No coin nor oath required. For personal study only.